 EMERYVILLE, Calif.--BUSINESS WIRE--Adamas Pharmaceuticals, Inc. Nasdaq: ADMS, a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today announced five posters will be presented at the International Parkinson and Movement Disorder Society MDS Virtual Congress, taking place September 17 22, 2021. The poster presentations will focus on GOCOVRI amantadine extended-release capsules, the first and only FD 